[ET Net News Agency, 27 November 2023] Citi lowered its target price for CR Medical
(01515) to HKD7 from HKD7.7 and upgraded its rating to "buy" from "neutral / high risk".
The research house said it upgrades the rating, considering the attractive valuation and
stable growth prospect ahead. (RC)